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Abstract
Complex mechanisms that detect changes in brainstem parenchymal PCO2/[H+] and trigger
adaptive changes in lung ventilation are responsible for central respiratory CO2 chemosen-
sitivity. Previous studies of chemosensory signalling pathways suggest that at the level of
the ventral surface of the medulla oblongata (VMS), CO2-induced changes in ventilation are
(at least in part) mediated by the release and actions of ATP and/or acetylcholine (ACh).
Here we performed simultaneous real-time biosensor recordings of CO2-induced ATP and
ACh release from the VMS in vivo and in vitro, to test the hypothesis that central respiratory
CO2 chemosensory transduction involves simultaneous recruitment of purinergic and cho-
linergic signalling pathways. In anaesthetised and artificially ventilated rats, an increase in
inspired CO2 triggered ACh release on the VMS with a peak amplitude of ~5 μM. Release of
ACh was only detected after the onset of CO2-induced activation of the respiratory activity
and was markedly reduced (by ~70%) by ATP receptor blockade. In horizontal slices of the
VMS, CO2-induced release of ATP was reliably detected, whereas CO2 or bath application
of ATP (100 μM) failed to trigger release of ACh. These results suggest that during hyper-
capnia locally produced ATP induces or potentiates the release of ACh (likely from the med-
ullary projections of distal groups of cholinergic neurones), which may also contribute to the
development and/or maintenance of the ventilatory response to CO2.
Introduction
Breathing is a vital physiological function that maintains constant levels of the arterial and
brain PCO2/pH to support metabolic demands under ever-changing physiological and envi-
ronmental conditions. Arterial blood gases and pH are monitored by the peripheral chemore-
ceptors located in the carotid and (in some species) aortic bodies, [1, 2] and central
chemoreceptors located within the medulla oblongata [3, 4]. Ventilatory responses to the
increases in arterial PCO2 are largely preserved after peripheral chemodenervation [5] and
resection of the pons and dorsal medulla [6], suggesting that the ventral regions of the medulla
oblongata are sensitive to, and mediate, the actions of CO2 on breathing [7–10]. Current
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models of central respiratory CO2 chemosensitivity have centred around the function of the
so-called retrotrapezoid nucleus (RTN) located near the ventral surface of the medulla (VMS)
oblongata, as loss of RTN neurons abolishes CO2-induced recruitment of the expiratory activ-
ity and significantly reduces CO2-induced enhancement of the inspiratory activity [11–13].
Early investigations of the signalling mechanisms underlying central respiratory CO2 che-
mosensitivity suggested that at the VMS, acidification-induced changes in breathing are medi-
ated by the release and actions of acetylcholine (ACh) [14, 15]. It was reported recently that
ACh is indeed able to increase the excitability of chemosensitive RTN neurones via activation
of muscarinic receptors and subsequent inhibition of KCNQ channels [16]. There is also evi-
dence indicating that the central respiratory chemosensory transduction is mediated by the
actions of ATP released by the VMS astrocytes [9, 17–21]. Therefore, central respiratory CO2
chemosensory transduction may involve simultaneous recruitment of purinergic and choliner-
gic signalling pathways similar to those employed for chemosensory transduction in the
carotid body [22–24]. Here we tested this hypothesis by making simultaneous real-time bio-
sensor recordings of CO2-evoked release of ATP and ACh from the VMS in anaesthetised and
artificially ventilated rats, and reduced preparations of the VMS in vitro. We also determined
the effect of ATP receptor blockade on ACh release during systemic hypercapnia.
Methods
ATP and ACh biosensors
ATP, ACh, Choline (Ch), and null biosensors were obtained from Sarissa Biomedical Ltd
(Coventry, UK). The design and operation of enzymatic ATP biosensors have been described
in detail previously [25, 26]. Null sensors, which lack enzymes in the deposition layer, were
used to control for the potential release of non-specific electrochemical signals in the experi-
ments involving detection of ATP. ACh sensors utilise two enzymes, acetylcholine esterase
and choline oxidase, entrapped within a sol-gel matrix around a Pt wire (50 or 100 μm in
diameter and 0.5 or 2 mm long) (Fig 1A and 1C). These enzymes degrade ACh to betaine alde-
hyde and H2O2 which is detected electrochemically (Fig 1C). Ch sensors, which only contain
choline oxidase in the matrix layer, were used to control for the potential release of choline or
non-specific electroactive interferents (Fig 1D). Subtraction of control sensor (null or Ch) cur-
rents from ATP and ACh biosensor currents produced the netATP and netACh readings used
for the analysis (Fig 1E).
These recording configurations were used for all the experiments except for simultaneous
measurements of ATP and ACh release in vivo once a sufficient number of controls had been
performed to be confident that the sensors, due to their permselective screening layer, do not
detect electroactive interferents released during CO2 challenges. Furthermore, a sufficient
number of tests had also been performed showing that Ch is not detected in the absence of
ACh, therefore any detection of Ch by the ACh sensor was secondary to the breakdown of
ACh by tissue acetylchloline esterase. Before and after each of the experiments, the sensors
were calibrated using 10 μM ATP, ACh, and Ch (Fig 1B and 1E). Sensors were also regularly
tested against 10 μM 5-HT to assess the integrity of the sensor permselective screening layer
and any reactivity to potential electroactive interferents. Calibrations of sensors used in the in
vivo experiments were performed in a flow chamber at room temperature. Enzymatic ampero-
metric biosensors have only a small degree of temperature sensitivity. Whilst the absolute
increases in ATP and ACh release might have been slightly over-estimated, as all experimental
conditions were compared against controls in the same preparation, the relative changes in
ATP and ACh concentrations under various conditions were the same. Sensors used in the in
vitro experiments were calibrated at 33˚C in the recording chamber.
ACh Release from the Medulla Oblongata
PLOS ONE | DOI:10.1371/journal.pone.0167861 December 9, 2016 2 / 11
Experimental animals and ethical approval
All experiments were performed in accordance with the European Commission Directive
2010/63/EU (European Convention for the Protection of Vertebrate Animals used for Experi-
mental and Other Scientific Purposes) and the UK Home Office (Scientific Procedures) Act
(1986) with project approval from the Institutional Animal Care and Use Committees of the
University College London and the University of Warwick
Chemoreception changes with age, and this must be taken into the account when studying
the mechanisms underlying the CO2 ventilatory response [10]. In this study only adult rats
were used as the contribution of CO2-induced ATP release to the hypercapnic ventilatory
response is well documented in rats of this age range [17, 18, 27, 28].
In vivo preparation
Sixteen male Sprague-Dawley rats (300–340 g) were anaesthetised with sodium pentobarbi-
tone (60 mg.kg-1, i.p.). We previously demonstrated that CO2-induced release of ATP is pre-
served in animals anaesthetised with pentobrabitone or urethane [9, 17]. Adequate depth of
Fig 1. Principles of operation and performance of acetylcholine (ACh) biosensors. (A) Schematic of the sensor assembly. (B) Calibration curve of a 2
mm ACh biosensor demonstrating linearity of ACh detection in concentrations between 0.5 and 10 μM. (C) Enzymatic cascade used to detect ACh. In the
presence of ACh, the enzymatic cascade generates H2O2, which is detected electrochemically. (D) Biosensor placements on the ventral medullary surface. In
vivo, 2 mm sensors were placed in direct contact with the ventral surface of the medulla (VMS) overlaying the rostral (R), intermediate (I) and caudal (C)
chemosenitive areas. In vitro, 0.5 mm sensors were placed on the VMS within either the rostral or caudal chemosenitive areas. Arrow shows the direction of
aCSF flow across the brainstem slice. (E) Representative traces illustrating the responses of ATP, null, ACh, and Ch biosensors to ATP and ACh (calibration
of 0.5 mm sensors following in vitro experiments). Subtracting null sensor current from the ATP biosensor current and subtracting Ch biosensor current from
ACh biosensor current produce netATP and netACh signals, respectively.
doi:10.1371/journal.pone.0167861.g001
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anaesthesia was monitored through recordings of the respiratory activity (as measured by
phrenic nerve discharge), systemic arterial blood pressure and heart rate.
The femoral vein was cannulated for administration of supplemental anaesthetic (sodium
pentobarbitone, 10-15 mg.kg-1.hr-1). The trachea was cannulated and the animal was mechani-
cally ventilated with a tidal volume of ~2 ml and a respiratory frequency of ~60 strokes.min-1
with O2-enriched air (50% O2/50% N2). The rat was then placed in a stereotaxic frame and
neuromuscular blockade was applied (gallamine triethiodide, 30 mg.kg-1, i.v.; with supplemen-
tal doses given as required, 3-6 mg.kg-1.h-1). The VMS was exposed as described previously
[9]. Phrenic nerve activity was recorded as a measure of central respiratory drive. The signal
was amplified (x20,000), filtered (500–1500 Hz), rectified and smoothed (τ = 50 ms). PO2,
PCO2 and pH of the arterial blood were measured regularly (every 1–2 h) using a blood gas
analyser (Siemens). End-tidal CO2 was monitored on-line using a small animal fast-response
CO2 analyser (model Capstar-100, CWE Inc.). PaO2 was kept at>100 mmHg to minimize
drive from the peripheral chemoreceptors. Body temperature was maintained with a servo-
controlled heating pad at 37.0±0.5˚C.
Measurements of CO2-induced ATP and ACh release on the VMS in
vivo
ATP, ACh, Ch, and null biosensors (length of the sensitive tip 2 mm; 100 μm in diameter)
were held on a stereotaxic micromanipulator and connected to MicroC potentiostats (WPI).
The sensors were bent and the sensing part was laid flat against the VMS and aligned with the
pyramidal tracts ~1.5–2.0 mm lateral from the midline (Fig 1D), to maximise the surface area
of the biosensor in direct contact with the chemosensitive areas of the VMS including the
RTN. Control (null or Ch) sensors were placed in equivalent positions on the contralateral
side of the VMS (Fig 1D) as described in detail previously [9, 17] (see Fig 1 in Ref 9). Once the
sensors were placed, a period of ~30 mins was allowed until a steady baseline was achieved. To
determine the temporal relationship between ATP and/or ACh release on the VMS with CO2-
evoked increases in respiratory activity, hypocapnic apnoea was induced by mechanical hyper-
ventilation to keep arterial PCO2 and end-tidal CO2 below the apnoeic threshold. CO2 was
then added to the respiratory mixture until end tidal CO2 was ~8% for a period of 3–5 min.
To determine the causal relationship between ATP and ACh release, P2 receptor antagonist
pyridoxal-phosphate-6-azophenyl-2’,4’-disulfonate (PPADS, 200 μM) was applied to the VMS
for 30 min and CO2-evoked ACh release was determined. The VMS was washed and after a
recovery period of 30–60 min the response to CO2 was retested.
To determine the temporal relationship between CO2-induced ACh and ATP release, both
transmitters were recorded simultaneously using their respective biosensors in the same prep-
arations (n = 8). These recordings were also used to determine the temporal relationship
between the onset of ATP release and adaptive increases in the respiratory activity (n = 8). To
determine the effect of PPADDS on ACh release, the dual recording configuration of ACh and
null sensors was used (n = 8). To determine the temporal relationship between the onset of
ACh release and adaptive increases in breathing, the data from both of these experiments were
pooled (n = 16).
In vitro slice preparation
Young adult rats (4–6 weeks old; n = 6) were used for the in vitro experiments as preparation
of the horizontal brainstem slice is significantly easier than in older adult rats. We previously
reported [17] that CO2-induced ATP release mechanisms are similar in young and older adult
rats. The animals were humanely sacrificed by isoflurane overdose. Their brainstems were
ACh Release from the Medulla Oblongata
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rapidly dissected free from the skull and placed in a chilled (~5˚C) artificial cerebrospinal fluid
(aCSF) containing: 124 mM NaCl, 3 mM KCl, 1 mM CaCl2, 26 mM NaHCO3, 1.25 mM
NaH2PO4, 1 mM MgSO4, 10 mM D-glucose (saturated with 95% O2/5% CO2; pH 7.5) with an
additional 10 mM Mg2+. A 400 μm thick horizontal slice of the brainstem containing the VMS
was prepared as described in detail previously [17, 27], and placed on an elevated grid in a
recording chamber superfused with a standard aCSF at 33˚C at a rate of 6 ml.min-1. The sur-
face of the brainstem slice extended from the pontine border down to the bifurcation of the
basilar artery, thus containing almost the entire rostro-caudal extent of the VMS (Fig 1D). Lat-
erally, the surface of the slice extended from the midline to the areas located beyond the lateral
border of the facial nucleus on both sides [17, 27] (Fig 1D).
ATP, ACh, Ch, and null biosensors (0.5 mm in length, 50 μm in diameter) were bent and
the sensing part was laid flat on the VMS in either the rostral chemosensitive area overlying
the RTN or in the caudal chemosensitive region (as no differences in ATP or ACh release were
seen under any experimental conditions the data were pooled). The ATP and null sensors
were placed on the same side of the VMS juxtaposed to the pyramidal tracts, with ACh and Ch
sensors placed in equivalent positions on the contralateral side. To ensure any enzymatic
breakdown products from the ATP and ACh sensors did not reach the control sensors (null
and Ch), ATP and ACh sensors were placed downstream of the control sensors with respect to
the aCSF flow in the recording chamber (Fig 1D). Once the sensors were placed, a period of
~30 mins was allowed until a steady baseline was achieved.
To study the release of ATP and ACh in vitro, the VMS slices were exposed to a 5 min che-
mosensory stimulus followed by a 45 min recovery period. The chemosensory challenge
involved replacing normal aCSF with a solution containing: 100 mM NaCl, 50 mM NaHCO3,
3 mM KCl, 2 mM CaCl2, 1.25 mM NaH2PO4, 1 mM MgSO4, 10 mM Glucose, saturated with
9% CO2 (PCO2 ~55 mmHg, pH 7.5). This chemosensory stimulus was previously demon-
strated to induce robust ATP release from the VMS in vitro [17, 29, 30]. Following the recovery
period, 1 mM ATP was applied to determine the ability of P2 receptor activation to trigger
release of ACh. Glycerol (2 mM) was added to all the solutions to enable operation of ATP bio-
sensors. The pH within the recording chamber was monitored with a miniature pH sensitive
electrode (Harvard Apparatus).
Data analysis
In vivo records were acquired using Spike2 software (Cambridge Electronic Design); in vitro
records we acquired using custom-written software. All data were analysed with OriginPro
(OriginLab Corp.). The paired-sample Wilcoxon signed-rank test was used to compare the
time delays between the release of ACh and ATP in response to CO2. The one-sample Wil-
coxon signed rank test was used to analyse whether the peak release of ACh and ATP were dif-
ferent from 0. A one-way repeated measures ANOVA with Dunn-Sidak post-hoc analysis was
performed on ranked data to determine the effect of PPADS on ACh release. To exclude the
possibility that the effect of PPADS might be masked by generalized run-down of ACh release
over time, only experiments where there was at least a partial recovery of ACh release (8/10)
were included in the analysis. Data are reported as medians and interquartile ranges (IQR).
Differences with p< 0.05 were considered to be significant.
Results
The ACh sensors had a detection limit of 100 nM ACh, and responded linearly when ACh was
present in concentrations of up to 50 μM (Fig 1). Likewise, the Ch sensors had a detection
limit of 100 nM Ch, and had a linear response range in concentrations of up to 50 μM (data
ACh Release from the Medulla Oblongata
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not shown). The permselective layer blocked the interaction of electroactive interferents (e.g.
5-HT) with the platinum wire of all sensor types, and only small deflections in sensor current
were recorded during the application of the modified aCSF used to mimic the chemosensory
challenge in vitro (Fig 1E). Detection of ACh and Ch by the biosensors was also unaffected in
the presence of the P2 receptor antagonist PPADS. Therefore, netACh and netATP signals
recorded provided accurate measures of the release of these transmitters.
The potential role of ACh in the mechanisms of central respiratory chemosensory transduc-
tion was assessed by measuring its release from the VMS in real-time in anaesthetised, para-
lysed, and artificially ventilated rats (Fig 2). If ACh is one of the key signalling molecules of
central chemosensory transduction, its release should be induced by increases in the level of
inspired CO2, and should precede CO2-induced enhancement of the respiratory activity.
Increasing inspired CO2 was found to be associated with significant ACh release detected on
the VMS, which reached a peak amplitude of 4.7 μM (IQR = 4.3 μM; n = 16; P = 0.0004; Fig
2A). Release of ACh was detected 6.6 s (IQR = 11.7 s) after hypercapnia-induced activation of
respiration was recorded (n = 8, Fig 2A). Null sensors did not report any signal changes during
the chemosensory challenges, and Ch release was not detected in the absence of ACh release.
Therefore, the signal recorded by the ACh sensor was due to neither the release of non-specific
electroactive interferents nor the detection of Ch.
The time course of ACh release contrasted with that of ATP release, which always preceded
CO2-induced increases in phrenic nerve activity (Gourine et al., 2005b). Therefore, we next
assessed the temporal relationship of the release of these two transmitters, by making simulta-
neous paired measurements of ATP and ACh release on the VMS (Fig 2A). The onset of ATP
release was found to precede CO2-induced changes in central respiratory drive by 15.5 s
(IQR = 9.1 s), and therefore also the release of ACh (n = 8; P = 0.015; Fig 2A). No ACh release
was observed in response to a chemosensory challenge (isohydric hypercapnia) in horizontal
slices of the VMS (-0.7 μM; IQR = 1.2 μM; n = 8; P = 0.4), while the CO2-induced release of
ATP was reliably recorded (1.1 μM; IQR = 1.6 μM; n = 6; P = 0.04; Fig 2B).
The temporal differences in the release of these two transmitters in vivo suggested that ACh
may be released as a downstream consequence of ATP actions. To test this hypothesis, we
examined the effect of P2 receptor blockade (through topical application of PPADS) on ACh
release at the VMS. PPADS (200 μM) reduced CO2-induced release of ACh detected at the
VMS by ~70% (from 2.8 μM [IQR 5.6 μM] to 0.9 μM [IQR = 1.4 μM]; n = 8; p = 0.03, Fig 3).
Full recovery of ACh release was observed after PPADS washout (2.8 μM [IQR 2.1 μM]; n = 8;
P = 0.005 compared to PPADS; P = 0.8 compared to control values; Fig 3). Currents generated
by ACh biosensors during in vitro calibration with ACh (10 μM) were not reduced in the pres-
ence of PPADS (200 μM), indicating that this compound has no significant effect on the bio-
sensor detection system (Fig 3C). In horizontal VMS slices, application of ATP (100 μM) failed
to trigger significant ACh release (0.3 μM; IQR = 1.4 μM; n = 8; P = 1.0; Fig 3D), suggesting
that either ATP does not directly elicit ACh release and/or the VMS slice does not contain the
major source of ACh release observed in vivo.
Discussion
In a series of pioneering studies, Loeschcke and colleagues proposed a key role for ACh in cen-
tral respiratory chemosensory transduction [7]. This hypothesis was based on the observations
that ACh receptor antagonists reduce both the sensitivity of the respiratory network to CO2 in
vivo [14] and the pH-sensitivity of medullary (presumably RTN) neurones in vitro [15]. In
addition, Dev and Loeschcke also reported that topical applications of ACh or nicotine to pH-
sensitive areas of the VMS increase ventilation [14].
ACh Release from the Medulla Oblongata
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Results of the present study show that ACh release occurs too late to be responsible for
CO2-induced initiation of the respiratory activity from hypocapnic apnoea. Moreover, during
systemic hypercapnia, ACh release on the VMS was preceded by ATP release, and was
markedly reduced (by ~70%) by ATP receptor blockade following topical application of P2
antagonist. Though ACh release appears to depend on ATP actions, our data suggest that ATP
does not itself trigger ACh release, but instead augments it. We saw no evidence of ACh release
from the VMS in response to ATP in vitro, when ATP was either bath applied (Fig 3), or fol-
lowing ATP release in response to chemosensory challenge (Fig 2B), known to elicit ATP
release through connexin 26 hemichannels [17]. There is evidence that cholinergic neurons
Fig 2. Release of ACh and ATP on the ventral surface of the medulla oblongata during hypercapnia. (A) Representative recordings illustrating
changes in ACh and ATP concentration on the VMS in response to an increase in the level of inspired CO2 in anaesthetised, paralyzed and artificially
ventilated rats. Note that ATP release precedes ACh release, which occurs after the onset of CO2-induced enhancement of the respiratory activity. Arrows
denote when concentrations of ATP and ACh on the VMS start to increase. PNG–phrenic neurogram (arbitrary units). (B) Representative recordings
illustrating changes in ATP and ACh release from the VMS triggered by CO2 in vitro (horizontal brainstem slice).
doi:10.1371/journal.pone.0167861.g002
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which reside near the VMS are not involved in either cardiovascular or respiratory control
mechanisms [31]. Our observations that CO2 triggers ACh release in vivo, but not in the
reduced in vitro preparations of the VMS, suggest that the major source of this ACh release
resides outside of the VMS. Therefore, whereas in response to hypercapnia ATP is released by
the VMS astrocytes [17, 18, 32], ACh is likely to be derived from the medullary projections of
distal groups of cholinergic neurones, e.g. pontomesencephalic tegmental cholinergic complex
[33, 34]. This would also account for the observation that although ACh is able to excite RTN
neurones, muscarinic blockade has no effect on CO2/H
+-sensitivity of RTN neurones in vitro
[16].
We also noticed that whilst ATP release closely follows changes in end-tidal CO2 in vivo,
ACh release remains elevated for a more prolonged period. These different kinetics suggest
that ATP is released in response to increasing CO2 and is responsible for initiation of the respi-
ratory response to hypercapnia, whilst the release of ACh (which occurs later), may act to
maintain elevated respiratory activity after the levels of CO2 and ATP have returned to
baseline.
Fig 3. ACh release on the ventral surface of the medulla oblongata during hypercapnia is secondary to the release of ATP. (A) Representative
recordings obtained sequentially in the same experiment illustrating the effect of P2 receptor antagonist pyridoxal-5’-phosphate-6-azophenyl-2’,4’-disulphonic
acid (PPADS) on changes in ACh concentration on the VMS in response to the increases in inspired CO2. (B) Summary data illustrating CO2-induced peak
increases in ACh concentration on the VMS in the absence and presence of PPADS and after washout of the drug (n = 8). (C) Calibration of ACh biosensors
in vitro demonstrating that ACh (10 μM)-evoked currents are not reduced in the presence of PPADS (200 μM). (D) Representative recordings illustrating lack
of changes in ACh release from the VMS in response to bath application of ATP in vitro (horizontal brainstem slice).
doi:10.1371/journal.pone.0167861.g003
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Current concepts of central respiratory CO2 chemosensitivity pose that RTN neurons are
intrinsically pH-sensitive (this chemosensitivity is believed to be mediated by proton sensitive
GPCRs and K+ channels) [35], and play the key role in relaying changes in brainstem paren-
chymal pH into a modified pattern of breathing [36]. This model, however, cannot explain
why RTN neurones are not able to mount an appropriate respiratory response when the pH-
sensitivity of neighbouring astrocytes is compromised [37–39]. An alternative (or complimen-
tary) hypothesis proposes that distinct mechanisms underlie the sensitivity of medullary astro-
cytes to changes in PCO2 (direct CO2-sensing by connexin26 hemichannels) [29] and pH [32,
40] leading to the release of a common signalling molecule (ATP), which mediates CO2/H
+
actions on breathing within the medullary respiratory network, including the RTN [9, 17–20,
27, 28, 41, 42].
Summary
The results of the present study suggest that during systemic hypercapnia, locally released ATP
potentiates the release of ACh (from as of yet unknown sources), and these two transmitters
contribute to the initiation and maintenance of the ventilatory response to CO2.
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